Cellebrite's Reset Guidance Faces Its First Real Test Under New CEO Shiv Ramji

Three months ago Cellebrite asked investors to accept a smaller growth story in exchange for a more credible one. The digital forensics specialist cut its 2026 targets, missed its own second-quarter ARR guide, and swapped out its chief executive in the same breath. New CEO Shiv Ramji called the year an execution reset and declined to blame timing for the shortfall. The third-quarter report, due before the open on November 12, is the first chance to see whether that lower bar was set conservatively enough to clear.

On paper, the expectations look healthy. Consensus calls for earnings of $0.12 a share, up 50% from $0.08 a year ago, on revenue of $145.6 million, a 15.5% gain from $126.0 million. That would be a sharp step up from the $131.1 million and $0.05 posted last quarter. But the Street now sits near the bottom of management's $145 million to $148 million revenue range, after analysts had been modeling roughly $150 million before the guidance cut. In other words, forecasters have not fully trusted the reset. A result toward the middle or top of the range would suggest the slipped deals are closing. A print at the low end, or below it, would raise the uncomfortable possibility that the cut did not go far enough.

ARR is the number that matters most. Management lowered its year-end ARR target to $550 million to $560 million from $567 million to $573 million and reset its growth framework to 14% to 16% from 18% to 19%. With second-quarter ARR at $508 million, the company needs a steady build through the back half. Investors should look for clear progress toward that target and for evidence that the large deals delayed by new foreign-entity procurement rules in US federal and sovereignty audits in Europe are actually landing rather than sliding again. Repeated slippage would point to a structural lengthening of sales cycles, not a one-quarter hiccup.

The second test is Insights pricing. The uplift from converting customers to the Insights tier came in light, especially in US state and local government, where growth cooled to just under 20% from the mid-20s in 2025. Management trimmed that contribution to mid-single digits. Stabilization in state and local growth would validate the new framework. Further erosion would challenge it, because that segment has long been the company's engine. On the positive side, the US federal rebound to mid-teens growth and 25% growth in defense and intelligence need to persist, and Genesis, the AI product management described as its strongest launch ever, should show it has moved well past the roughly $1 million ARR mark cited last quarter. Follow-on activity from the first big FedRAMP Guardian order would add credibility to the cloud story.

Profitability offers some cushion. Cellebrite raised its adjusted EBITDA outlook to $153 million to $159 million, roughly a 28% margin, despite a currency headwind from the Israeli shekel. Holding that line through a leadership transition would show that spending discipline is real.

The market has been forgiving. Shares have climbed 18.7% since the last report, beating the S&P 500 by more than 21 points, and at $12.25 the stock is pressing against its post-earnings high of $12.43 after rebounding from $9.58. Yet it remains below its 200-day average of $13.37 and well beneath last quarter's $17.05 peak, and sentiment has turned more bearish than it was heading into the prior report. That mix leaves room in both directions. The core question is simple: did the reset create a floor? If ARR tracks toward the lowered target and deals close on schedule, the stock has a credible path through resistance. Another shortfall would suggest the reset was just the first cut.

This earnings preview was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.